Axs Investments LLC Gilead Sciences, Inc. Transaction History

Axs Investments LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Aug 16, 2024	BUY	$71.58 - $87.29 $207,224 - $252,704	2,895 New	2,895 $212,000
Q1 2024 May 13, 2024	BUY	$71.58 - $87.29 $60,485 - $73,760	845 Added 41.22%	2,895 $212,000
Q4 2023 Feb 09, 2024	SELL	$73.27 - $83.09 $21,614 - $24,511	-295 Reduced 12.58%	2,050 $166,000
Q3 2023 Nov 09, 2023	BUY	$73.94 - $80.67 $28,466 - $31,057	385 Added 19.64%	2,345 $175,000
Q2 2023 Aug 10, 2023	SELL	$76.01 - $86.7 $72,513 - $82,711	-954 Reduced 32.74%	1,960 $151,000
Q1 2023 May 12, 2023	BUY	$77.31 - $88.08 $43,293 - $49,324	560 Added 23.79%	2,914 $241,000
Q4 2022 Feb 13, 2023	SELL	$62.32 - $89.47 $108,187 - $155,319	-1,736 Reduced 42.44%	2,354 $202,000
Q3 2022 Nov 07, 2022	BUY	$59.54 - $68.01 $243,518 - $278,160	4,090 New	4,090 $252,000
Q1 2022 May 13, 2022	SELL	$57.92 - $72.58 $164,492 - $206,127	-2,840 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$64.88 - $73.64 $184,259 - $209,137	2,840 New	2,840 $206,000
Q3 2021 Nov 05, 2021	SELL	$67.69 - $73.03 $302,912 - $326,809	-4,475 Closed	0 $0
Q2 2021 Jul 28, 2021	BUY	$63.47 - $69.35 $284,028 - $310,341	4,475 New	4,475 $308,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Axs Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Axs Investments LLC with notifications on news.